Fort Myers-based cancer lab expects strong performance in 2025, with new CEO
NeoGenomics Inc. shared a strong financial outlook for 2025 and beyond. The Fort Myers-based cancer testing and research lab ...
Benchmark retains Hold on Neogenomics stock, raises 2025 revenue forecast
Benchmark analyst maintained a Hold rating on shares of Neogenomics (NASDAQ: NEO). The analysis comes ahead of the company's investor conference presentation scheduled for the same day. The company, ...
Dallas Observer9h
South Side Studios Reopens for (Show) Business
The completion of phase 1 of the production facility’s renovation was marked with a massive reception, showcasing the new ...